Literature DB >> 16390319

Parameters of LRP5 from a structural and molecular perspective.

Mark L Johnson1, Douglas T Summerfield.   

Abstract

LRP5, along with LRP6 and their Drosophila homolog, Arrow, constitute a novel subclass of the LDL receptor superfamily. The arrangement of structural motifs in these receptors is different from the other members of the superfamily, and only recently have we begun to understand the functional importance of human LRP5 (and LRP6). Whole genome positional cloning studies have identified a number of mutations in LRP5 that underlie inherited human diseases/phenotypes, particularly those involving the skeleton and the eye. A number of studies have illustrated the importance of Lrp5/6/Arrow as a co-receptor with Frizzled for the Wnt proteins and their critical role in the regulation of the Wnt/beta-catenin signaling pathway. The cataloging of these human mutations, in combination with engineered mutations in mice and other studies involving gene/protein modifications, has led to a better understanding of the function of the various domains in LRP5/6. In this review, we discuss a number of studies that have revealed a wide variety of protein-protein interactions that occur with the various structural motifs in the Lrp5 protein. Ultimately, these interactions regulate the activity of the Wnt/beta-catenin signaling pathway and the role it plays in processes such as bone mass accrual and vision.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16390319     DOI: 10.1615/critreveukargeneexpr.v15.i3.50

Source DB:  PubMed          Journal:  Crit Rev Eukaryot Gene Expr        ISSN: 1045-4403            Impact factor:   1.807


  13 in total

1.  Characterization of the interaction of sclerostin with the low density lipoprotein receptor-related protein (LRP) family of Wnt co-receptors.

Authors:  Gill Holdsworth; Patrick Slocombe; Carl Doyle; Bernadette Sweeney; Vaclav Veverka; Kelly Le Riche; Richard J Franklin; Joanne Compson; Daniel Brookings; James Turner; Jeffery Kennedy; Rachael Garlish; Jiye Shi; Laura Newnham; David McMillan; Mariusz Muzylak; Mark D Carr; Alistair J Henry; Thomas Ceska; Martyn K Robinson
Journal:  J Biol Chem       Date:  2012-06-13       Impact factor: 5.157

Review 2.  Diseases of Wnt signaling.

Authors:  Mark L Johnson; Nalini Rajamannan
Journal:  Rev Endocr Metab Disord       Date:  2006-06       Impact factor: 6.514

3.  The role of Lrp5/6 in cardiac valve disease: experimental hypercholesterolemia in the ApoE-/- /Lrp5-/- mice.

Authors:  Nalini M Rajamannan
Journal:  J Cell Biochem       Date:  2011-10       Impact factor: 4.429

4.  Crystal structures of the extracellular domain of LRP6 and its complex with DKK1.

Authors:  Zhihong Cheng; Travis Biechele; Zhiyi Wei; Seamus Morrone; Randall T Moon; Liguo Wang; Wenqing Xu
Journal:  Nat Struct Mol Biol       Date:  2011-10-09       Impact factor: 15.369

Review 5.  WNT signaling in bone development and homeostasis.

Authors:  Zhendong Zhong; Nicole J Ethen; Bart O Williams
Journal:  Wiley Interdiscip Rev Dev Biol       Date:  2014-09-30       Impact factor: 5.814

6.  LRP5 and bone mass regulation: Where are we now?

Authors:  Mark L Johnson
Journal:  Bonekey Rep       Date:  2012-01-10

7.  N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation.

Authors:  Eric Haÿ; Emmanuel Laplantine; Valérie Geoffroy; Monique Frain; Thomas Kohler; Ralph Müller; Pierre J Marie
Journal:  Mol Cell Biol       Date:  2008-12-15       Impact factor: 4.272

Review 8.  Myxomatous mitral valve disease bench to bedside: LDL-density-pressure regulates Lrp5.

Authors:  Nalini M Rajamannan
Journal:  Expert Rev Cardiovasc Ther       Date:  2014-03

9.  LRP5 sequence and polymorphisms in the baboon.

Authors:  Alison F Doubleday; Frederika A Kaestle; Laura A Cox; Shifra Birnbaum; Michael C Mahaney; Lorena M Havill
Journal:  J Med Primatol       Date:  2009-04       Impact factor: 0.667

Review 10.  Wnt signaling in bone and muscle.

Authors:  Michael A Rudnicki; Bart O Williams
Journal:  Bone       Date:  2015-11       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.